CoChat

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

Open access
Forlenza, Orestes V., Radanovic, Marcia, Talib, Leda L., Aprahamian, Ivan, Diniz, Breno S., Zetterberg, Henrik, Gattaz, Wagner F. · 2015 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Cited by 109

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Introduction: Guidelines for the use of cerebrospinal fluid (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) establish that each laboratory must use internally qualified cutoff values. We determined the concentrations of biomarkers that discriminate cases from controls and combinations that predict the progression to dementia in a Brazilian cohort. Methods: Concentrations of amyloid‐beta peptide (Aβ 1–42), total tau (T‐tau), and 181 Thr‐phosphorylated‐tau (P‐tau) were determined in CSF samples from 184 older adults (68 mild cognitive impairment, 41 AD, 34 non‐AD cognitive impairment, and 41 controls) by the INNO‐BIA AlzBio3 assay. Results: Cutoff values discriminating AD from controls are as follows: Aβ 1–42: 416.0 pg/mL (sensitivity [SE]: 83%, specificity (SP): 70%); T‐tau: 76.7 pg/mL (SE: 82%, SP: 67%); P‐tau: 36.1 pg/mL (SE: 83%, SP: 49%); Aβ 1–42/P‐tau <9.53 (SE: 88%, SP: 78%); and Aβ 1–42/T‐tau <4.13 (SE: 80%; SP: 80%). Combining values Aβ 1–42 <416.5 pg/mL and Aβ 1–42/P‐tau <9.5 best predicted the conversion in 2 years (Cox regression: hazard ratio 7.24 [2.09–25.06], P = .002, SE: 74%, Sp: 73%). Discussion: Our findings are in line with most of the available evidence in this field; yet, our cutoff values are different from those derived from other laboratories.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dadm.2015.09.003

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 109

Metadata

Authors
Forlenza, O. V., Radanovic, M., Talib, L. L., Aprahamian, I., Diniz, B. S., Zetterberg, H., & Gattaz, W. F.
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2015-10-02
Volume
1
Issue
4
Pages
455-463
ISSN
2352-8729 (ISSN-L)
OpenAlex
W1957710718
Cited by
109
References
18
FWCI
6.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia. https://app.cochat.ai/papers/10.1016/j.dadm.2015.09.003
The paper
Forlenza, O. V., Radanovic, M., Talib, L. L., Aprahamian, I., Diniz, B. S., Zetterberg, H., & Gattaz, W. F. (2015). Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2015.09.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.